vimarsana.com

Latest Breaking News On - Quarter for apellis pharmaceuticals - Page 8 : vimarsana.com

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Holdings Decreased by Picton Mahoney Asset Management

Picton Mahoney Asset Management reduced its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 12.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,727 shares of the company’s stock after selling 6,048 shares during the quarter. […]

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Shares Sold by Fiduciary Trust Co

Fiduciary Trust Co. lowered its position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 49.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 273,916 shares of the company’s stock after selling 268,375 shares during the quarter. Fiduciary Trust Co.’s holdings in Apellis Pharmaceuticals […]

Insider Selling: Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Director Sells 1,250 Shares of Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) Director Alec Machiels sold 1,250 shares of Apellis Pharmaceuticals stock in a transaction that occurred on Tuesday, October 17th. The shares were sold at an average price of $48.50, for a total transaction of $60,625.00. Following the completion of the transaction, the director now directly owns 367,420 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.